INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2008

A fungal beta-glucan preparation was tolerated by advanced cancer patients receiving chemotherapy.

In this phase I/II trial, 20 patients with advanced malignancies receiving chemotherapy received a beta-(1,3)/(1,6) D-glucan formulation. Investigators monitored participants for tolerability and effects on blood cell production. The authors concluded that the fungal supplement was well-tolerated and may have a beneficial effect on hematopoiesis during chemotherapy.

Study type
Phase I/II clinical trial
Who was studied
20 patients with advanced malignancies receiving chemotherapy
What was measured
Tolerability and effects on hematopoiesis

THE PAPER

A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy.

Weitberg AB. J Exp Clin Cancer Res, 2008.

PubMed 18803849 ↗DOI 10.1186/1756-9966-27-40 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.